Clinical Trials Logo

Clinical Trial Summary

Purpose: To document data on effectiveness of NEURAPAS® balance (NPB) in the treatment of nervous restlessness in children aged 6 to 12. Each patient is treated with NPB. No placebo group is established. Course and severity of symptoms is documented by a questionnaire on 13 common symptoms of nervous restlessness and a Visual Analogue Scale (VAS). A standardized questionnaire (Parent Child Behaviour Checklist (CBCL/4-18)) is completed. Choice and doses of therapy are at the respective physician's discretion. The planned treatment and observation period is 2 - 4 weeks.


Clinical Trial Description

Purpose: To document data on effectiveness of NEURAPAS® balance (NPB) in the treatment of nervous restlessness in children aged 6 to 12. Patients and methods: A prospective, non-interventional, non-randomized, observational study conducted in German pediatric practices. Each patient is treated with NPB. No placebo group is established. As subjective criteria to document course and severity of symptoms, a questionnaire on 13 common symptoms of nervous restlessness and a Visual Analogue Scale (VAS) is used. As an objective criterion, a standardized questionnaire (Parent Child Behaviour Checklist (CBCL/4-18)) is completed. Choice and doses of therapy are at the respective physician's discretion. The planned treatment and observation period is 2 - 4 weeks. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01125579
Study type Observational
Source Pascoe Pharmazeutische Praeparate GmbH
Contact
Status Completed
Phase
Start date March 2008
Completion date November 2008

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03608449 - Doing More With Less": Optimizing Psychotherapeutic Services in the Mental Health System N/A
Completed NCT02752295 - Intensive Stress Coping Intervention Week - A Secondary Prevention For Real World Affective Disorder Patients N/A
Completed NCT00163865 - A Pilot Study of Boredom in a Community Sample of Adolescents and a Clinical Sample of Adolescents N/A
Completed NCT03033420 - Reducing the Rate and Duration of Re-ADMISsions Among Patients With Unipolar Disorder and Bipolar Disorder Using Smartphone-based Monitoring and Treatment - The RADMIS Trials N/A
Completed NCT03109028 - Mental Health in Refugees and Asylum Seekers N/A
Completed NCT03667729 - The Effects of Progressive Muscle Relaxation Therapy in Patients With Schizophrenia N/A
Not yet recruiting NCT02095457 - Routine Outcome Monitoring in Mental Health Outpatient N/A
Completed NCT01815398 - Cognitive Skills Training for Homeless Youth N/A
Completed NCT02675257 - Depression and Diabetes Control Trial N/A
Completed NCT05379244 - Better Sleep in Psychiatric Care - Depression, Anxiety and Trauma, Pilot Study N/A
Completed NCT03335696 - Predicting MRI Abnormalities With Longitudinal Data of the Whitehall II Substudy
Completed NCT00288782 - PET Neuroimaging of [11C]Mirtazapine Phase 4
Completed NCT00199940 - Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic Illness Phase 4
Recruiting NCT01182012 - Reduction of Cardiovascular Risk in Severe Mental Illness Phase 4
Completed NCT00340379 - Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression Phase 2/Phase 3